04.106.2025 - Isomorphic Labs Rethinks Drug Discovery With AI

	Isomorphic Labs is reimagining the drug discovery process with an AI-first approach. At the heart of this work is a new way of thinking about biology. Max Jaderberg, chief AI officer, and Sergei Yakneen, chief technology officer at Isomorphic Labs joined the AI Podcast to explain why they look at biology as an information processing Read Article - View Press Release - Visit NVIDIA Corporation